YungShin Global Holding Corporation (3705.TW)
TWD 54.0
(0.75%)
TWD 54.0
(0.75%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.23 Billion TWD | -32.29% |
| 2022 | 1.83 Billion TWD | -32.91% |
| 2021 | 2.72 Billion TWD | -22.54% |
| 2020 | 3.52 Billion TWD | 6.2% |
| 2019 | 3.31 Billion TWD | -0.07% |
| 2018 | 3.31 Billion TWD | 17.77% |
| 2017 | 2.81 Billion TWD | 18.32% |
| 2016 | 2.38 Billion TWD | 59.01% |
| 2015 | 1.49 Billion TWD | 33.81% |
| 2014 | 1.11 Billion TWD | 5.65% |
| 2013 | 1.05 Billion TWD | 30.94% |
| 2012 | 809.13 Million TWD | 85.88% |
| 2011 | 435.3 Million TWD | 32.57% |
| 2010 | 328.35 Million TWD | 23.27% |
| 2009 | 266.36 Million TWD | -25.68% |
| 2008 | 358.42 Million TWD | 0.0% |
| 2006 | 155.81 Million TWD | -15.81% |
| 2005 | 185.07 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.05 Billion TWD | 10.98% |
| 2024 Q1 | 952.76 Million TWD | -23.13% |
| 2023 Q2 | 1.22 Billion TWD | -10.51% |
| 2023 Q3 | 1.37 Billion TWD | 12.39% |
| 2023 Q1 | 1.37 Billion TWD | -25.09% |
| 2023 Q4 | 1.23 Billion TWD | -10.13% |
| 2023 FY | 1.23 Billion TWD | -32.29% |
| 2022 Q1 | 2.72 Billion TWD | -0.07% |
| 2022 Q4 | 1.83 Billion TWD | -16.46% |
| 2022 Q3 | 2.19 Billion TWD | -20.6% |
| 2022 Q2 | 2.75 Billion TWD | 1.22% |
| 2022 FY | 1.83 Billion TWD | -32.91% |
| 2021 FY | 2.72 Billion TWD | -22.54% |
| 2021 Q4 | 2.72 Billion TWD | -10.04% |
| 2021 Q3 | 3.03 Billion TWD | 10.43% |
| 2021 Q2 | 2.74 Billion TWD | -2.47% |
| 2021 Q1 | 2.81 Billion TWD | -20.05% |
| 2020 Q1 | 3.25 Billion TWD | -1.92% |
| 2020 FY | 3.52 Billion TWD | 6.2% |
| 2020 Q2 | 3.03 Billion TWD | -6.71% |
| 2020 Q3 | 3.64 Billion TWD | 20.07% |
| 2020 Q4 | 3.52 Billion TWD | -3.35% |
| 2019 FY | 3.31 Billion TWD | -0.07% |
| 2019 Q2 | 3.32 Billion TWD | -0.41% |
| 2019 Q3 | 3.59 Billion TWD | 8.12% |
| 2019 Q4 | 3.31 Billion TWD | -7.8% |
| 2019 Q1 | 3.34 Billion TWD | 0.67% |
| 2018 Q2 | 2.71 Billion TWD | -2.58% |
| 2018 FY | 3.31 Billion TWD | 17.77% |
| 2018 Q3 | 3.57 Billion TWD | 31.83% |
| 2018 Q4 | 3.31 Billion TWD | -7.14% |
| 2018 Q1 | 2.78 Billion TWD | -1.24% |
| 2017 Q3 | 3.09 Billion TWD | 14.48% |
| 2017 Q2 | 2.7 Billion TWD | -0.08% |
| 2017 Q1 | 2.7 Billion TWD | 13.66% |
| 2017 FY | 2.81 Billion TWD | 18.32% |
| 2017 Q4 | 2.81 Billion TWD | -8.99% |
| 2016 FY | 2.38 Billion TWD | 59.01% |
| 2016 Q2 | 1.92 Billion TWD | 20.91% |
| 2016 Q4 | 2.38 Billion TWD | 1.89% |
| 2016 Q1 | 1.59 Billion TWD | 6.48% |
| 2016 Q3 | 2.33 Billion TWD | 21.22% |
| 2015 Q3 | 1.35 Billion TWD | 0.82% |
| 2015 FY | 1.49 Billion TWD | 33.81% |
| 2015 Q4 | 1.49 Billion TWD | 10.75% |
| 2015 Q2 | 1.34 Billion TWD | 5.47% |
| 2015 Q1 | 1.27 Billion TWD | 13.63% |
| 2014 Q3 | 1.03 Billion TWD | -1.73% |
| 2014 Q2 | 1.05 Billion TWD | -3.86% |
| 2014 Q1 | 1.09 Billion TWD | 3.31% |
| 2014 FY | 1.11 Billion TWD | 5.65% |
| 2014 Q4 | 1.11 Billion TWD | 8.25% |
| 2013 Q1 | 709.1 Million TWD | -12.36% |
| 2013 Q2 | 793.44 Million TWD | 11.89% |
| 2013 Q4 | 1.05 Billion TWD | -3.12% |
| 2013 Q3 | 1.09 Billion TWD | 37.83% |
| 2013 FY | 1.05 Billion TWD | 30.94% |
| 2012 Q2 | 606.56 Million TWD | 35.09% |
| 2012 Q3 | 746.17 Million TWD | 23.02% |
| 2012 Q4 | 809.13 Million TWD | 8.44% |
| 2012 FY | 809.13 Million TWD | 85.88% |
| 2012 Q1 | 449.01 Million TWD | 3.15% |
| 2011 Q3 | 391.12 Million TWD | -15.31% |
| 2011 FY | 435.3 Million TWD | 32.57% |
| 2011 Q1 | - TWD | -100.0% |
| 2011 Q2 | 461.82 Million TWD | 0.0% |
| 2011 Q4 | 435.3 Million TWD | 11.3% |
| 2010 FY | 328.35 Million TWD | 23.27% |
| 2010 Q4 | 328.35 Million TWD | 0.0% |
| 2009 FY | 266.36 Million TWD | -25.68% |
| 2008 FY | 358.42 Million TWD | 0.0% |
| 2006 FY | 155.81 Million TWD | -15.81% |
| 2005 FY | 185.07 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Grape King Bio Ltd | 192.92 Million TWD | -542.455% |
| Standard Chem & Pharm CO., LTD. | 1.08 Billion TWD | -14.549% |
| Maywufa Company Ltd. | 442.66 Million TWD | -179.991% |
| ScinoPharm Taiwan, Ltd. | 621.1 Million TWD | -99.552% |
| Lotus Pharmaceutical Co., Ltd. | 11.58 Billion TWD | 89.301% |
| LIWANLI Innovation Co., Ltd. | 2.63 Million TWD | -46919.158% |
| PhytoHealth Corporation | 28.11 Million TWD | -4308.412% |
| SCI Pharmtech, Inc. | 1.04 Billion TWD | -18.893% |
| Formosa Laboratories, Inc. | 4.06 Billion TWD | 69.505% |
| PharmaEssentia Corporation | 1.2 Billion TWD | -3.266% |
| Bora Pharmaceuticals Co., LTD. | 5 Billion TWD | 75.26% |